logo
T2

Exhibiting at Thaifex Anuga Asia, 2024

Hall: 9 Booth: 9-EE53
IMPACT MUANG THONG THANI BANGKOK, THAILAND
28 May - 1 Jun, 2024

Product Offerings

Product Categories:

Pharmaceutical Products, Pharmaceuticals, Biotechnology Products

Products:

Clinical Development Services, Qilong Capsule, Drugs, Various Cardiovascular Drugs

Qilong Biotechnology Group Co., Ltd, established in 2015, is a prominent player in the biotechnology sector in China. The company specializes in developing and producing pharmaceutical products, particularly focusing on treatments for cardiovascular and nervous system diseases. They are known for their Qilong capsule, a patented Chinese medicine approved by China's FDA for ischemic stroke. The company is involved in various stages of drug development, including clinical trials and patent filings.